The balance between glutamate dehydrogenaseand aminotransferase activity in tumor cells has been shown to vary as demonstratedby changing KRAS expression in pancreatic cancer cells [16], so the actual direction of flux between glutamate andα-ketoglutarate may vary depending on cell type. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.